Yesterday, Singota Solutions’ Founder and CEO, Alisa Kilgas, took the stage at the Indiana Life Sciences Manufacturing 2025 Summit, sharing invaluable insights on onshoring, life sciences resources, and talent development, as a panelist for the discussion “Indiana Perspective on Onshoring.” Her expertise, entrepreneurial spirit, and deep industry knowledge made for a compelling and insightful conversation, reinforcing Singota’s commitment to shaping the future of life sciences manufacturing.
Navigating the Complexities of Onshoring in Pharma
Onshoring has become a critical topic in the pharmaceutical world, with companies and policymakers alike seeking solutions to strengthen domestic supply chains and reduce reliance on overseas manufacturing. Kilgas provided a deep dive into the Indiana life sciences landscape, addressing key factors that make the state a prime location for pharmaceutical innovation. From the availability of advanced bio facilities to critical drug development resources and other essential components, she highlighted Indiana’s unique position in fostering a self-sustaining and resilient ecosystem for life sciences manufacturing.
Kilgas also emphasized the importance of supporting entrepreneurship in the life sciences sector. As the leader of a privately held, flexible, and client-focused CDMO, she understands firsthand the challenges of launching and scaling operations in an industry where regulatory requirements, supply chain disruptions, and access to capital all play major roles. She stressed the need for greater collaboration between established industry players and emerging biotech startups, ensuring that entrepreneurs have the resources, mentorship, and infrastructure needed to thrive in this rapidly evolving landscape.
The Talent Equation: Finding and Keeping Industry Leaders
Beyond infrastructure and supply chain considerations, one of the biggest challenges facing life sciences manufacturing is talent acquisition and retention. Kilgas addressed this issue in the panel discussion, sharing insights into Singota’s approach to attracting, developing, and keeping top-tier talent. She spoke about the need for continuous professional development, a strong company culture, and the importance of creating an environment where employees feel valued, engaged, and empowered to innovate.
With Indiana emerging as a major life sciences hub, nurturing and retaining scientific talent is crucial to sustaining growth. Kilgas champions investment in workforce training, STEM education partnerships, and mentorship programs that can help bridge the gap between academia and industry, discussing the concept that the industry must work together to cultivate the next generation of life sciences professionals, ensuring that innovation continues to flourish in Indiana and beyond.
Singota Solutions: A Leader in Industry Conversations
Kilgas’ participation in today’s event exemplifies Singota’s leadership in shaping the future of life sciences manufacturing. Her powerful voice added a critical perspective on the realities of drug development and manufacturing, providing valuable insights into the infrastructure, resources, and strategic planning required for success in today’s complex regulatory and economic landscape.
At Singota, we take pride in being at the forefront of these important industry discussions. Seeing our fearless leader engage in meaningful dialogue, advocate for innovation, and share her wealth of knowledge with peers and industry professionals was truly inspiring. Events like this reinforce Singota’s commitment to supporting early-phase drug developers, offering tailored CDMO solutions, and playing a pivotal role in the advancement of pharmaceutical manufacturing.
As the industry continues to evolve, Singota Solutions (Bloomington, Indiana CDMO) remains dedicated to driving innovation, fostering collaboration, and ensuring that all clients have the resources they need to succeed.
We look forward to continuing the conversation and working together to build a stronger, resilient pharmaceutical landscape.
